Literature DB >> 15100318

Activation of endoplasmic reticulum-specific stress responses associated with the conformational disease Z alpha 1-antitrypsin deficiency.

Matthew W Lawless1, Catherine M Greene, Alan Mulgrew, Clifford C Taggart, Shane J O'Neill, Noel G McElvaney.   

Abstract

Conformational diseases are a class of disorders associated with aberrant protein accumulation in tissues and cellular compartments. Z alpha1-antitrypsin (A1AT) deficiency is a genetic disease associated with accumulation of misfolded A1AT in the endoplasmic reticulum (ER) of hepatocytes. We sought to identify intracellular events involved in the molecular pathogenesis of Z A1AT-induced liver disease using an in vitro model system of Z A1AT ER accumulation. We investigated ER stress signals induced by Z A1AT and demonstrated that both the ER overload response and the unfolded protein response were activated by mutant Z A1AT, but not wild-type M A1AT. Interestingly, activation of the unfolded protein response pathway required an additional insult, whereas NF-kappa B activation, a hallmark of the ER overload response, was constitutive. These findings have important implications for the design of future therapeutics for Z A1AT liver disease and may also impact on drug design for other conformational diseases.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15100318     DOI: 10.4049/jimmunol.172.9.5722

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  71 in total

1.  Hepatic progenitor cell proliferation and liver injury in α-1-antitrypsin deficiency.

Authors:  Elizabeth M Brunt; Keith Blomenkamp; Muneeb Ahmed; Faiza Ali; Nancy Marcus; Jeffrey Teckman
Journal:  J Pediatr Gastroenterol Nutr       Date:  2010-11       Impact factor: 2.839

Review 2.  Gene therapy for alpha-1 antitrypsin deficiency.

Authors:  Terence R Flotte; Christian Mueller
Journal:  Hum Mol Genet       Date:  2011-04-16       Impact factor: 6.150

Review 3.  Protein misfolding and the serpinopathies.

Authors:  Didier Belorgey; Peter Hägglöf; Susanna Karlsson-Li; David A Lomas
Journal:  Prion       Date:  2007-01-06       Impact factor: 3.931

4.  A novel interaction between aging and ER overload in a protein conformational dementia.

Authors:  Angela Schipanski; Sascha Lange; Alexandra Segref; Aljona Gutschmidt; David A Lomas; Elena Miranda; Michaela Schweizer; Thorsten Hoppe; Markus Glatzel
Journal:  Genetics       Date:  2013-01-18       Impact factor: 4.562

5.  Abnormal disulfide-linked oligomerization results in ER retention and altered signaling by TNFR1 mutants in TNFR1-associated periodic fever syndrome (TRAPS).

Authors:  Adrian A Lobito; Fiona C Kimberley; Jagan R Muppidi; Hirsh Komarow; Adrianna J Jackson; Keith M Hull; Daniel L Kastner; Gavin R Screaton; Richard M Siegel
Journal:  Blood       Date:  2006-05-09       Impact factor: 22.113

6.  Z α-1 antitrypsin deficiency and the endoplasmic reticulum stress response.

Authors:  Catherine M Greene; Noel G McElvaney
Journal:  World J Gastrointest Pharmacol Ther       Date:  2010-10-06

Review 7.  Advances in alpha-1-antitrypsin deficiency liver disease.

Authors:  Jeffrey H Teckman; Ajay Jain
Journal:  Curr Gastroenterol Rep       Date:  2014-01

Review 8.  Serpins, immunity and autoimmunity: old molecules, new functions.

Authors:  Mariele Gatto; Luca Iaccarino; Anna Ghirardello; Nicola Bassi; Patrizia Pontisso; Leonardo Punzi; Yehuda Shoenfeld; Andrea Doria
Journal:  Clin Rev Allergy Immunol       Date:  2013-10       Impact factor: 8.667

9.  GCN2 protein kinase is required to activate amino acid deprivation responses in mice treated with the anti-cancer agent L-asparaginase.

Authors:  Piyawan Bunpo; Allison Dudley; Judy K Cundiff; Douglas R Cavener; Ronald C Wek; Tracy G Anthony
Journal:  J Biol Chem       Date:  2009-09-25       Impact factor: 5.157

Review 10.  Alpha1-antitrypsin deficiency: current perspective on research, diagnosis, and management.

Authors:  Jan Stolk; Niels Seersholm; Noor Kalsheker
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.